This federal contract award is for the delivery of Lynparza 100 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $20,359.02, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 9, 2024. The contract has a firm fixed-price pricing type and an ultimate completion date of December 31, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a comprehensive contracting mechanism for the DLA to procure a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. This specific award does not have a set-aside designation, indicating open competition.
Generated 3/16/25, 12:49 AM